Lymphangiogenesis and Anti-Tumor Immune Responses

E-ISSN： 1875-5666|9|6|694-701

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.9, Iss.6, 2009-08, pp. : 694-701

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

B cell-mediated down-regulation of IFN-γ and IL-12 production induced during anti-tumor immune responses in the tumor-bearing state

By Wijesuriya R. Maruo S. Sou J-P. Ogawa M. Umehara K. Yamashita M. Ono S. Fujiwara H. Hamaoka T.

International Immunology, Vol. 10, Iss. 8, 1998-08 ,pp. : 1057-1065

Oxford University Press

Access to resources Recommend Favorite

MUC1‐specific anti‐tumor responses: molecular requirements for CD4‐mediated responses

By VanLith Michelle L. Kohlgraf Karl G. Sivinski Connie L. Tempero Richard M. Hollingsworth Michael A.

International Immunology, Vol. 14, Iss. 8, 2002-08 ,pp. : 873-882

Oxford University Press

Access to resources Recommend Favorite

The role of parity status on cigarette smoke-induced modulation of anti-tumor immune mechanisms

By Vancza Elizabeth Ng Sheung Pui Harkema Jack Zelikoff Judith

Journal of Immunotoxicology, Vol. 6, Iss. 2, 2009-04 ,pp. : 94-103

Informa Healthcare

Access to resources Recommend Favorite

Systematic Review of Anti-Tumor Necrosis Factor-alpha Therapy for Treatment of Immune-mediated Uveitis

By Cordero-Coma Miguel

Ocular Immunology and Inflammation, Vol. 21, Iss. 1, 2013-02 ,pp. : 12-20

Informa Healthcare

Access to resources Recommend Favorite

LYVE-1, the lymphatic system and tumor lymphangiogenesis

By Jackson D.G. Prevo R. Clasper S. Banerji S.

Trends in Immunology, Vol. 22, Iss. 6, 2001-06 ,pp. : 317-321

Elsevier

Access to resources Recommend Favorite